314 related articles for article (PubMed ID: 24928858)
61. Whole-genome cartography of p53 response elements ranked on transactivation potential.
Tebaldi T; Zaccara S; Alessandrini F; Bisio A; Ciribilli Y; Inga A
BMC Genomics; 2015 Jun; 16(1):464. PubMed ID: 26081755
[TBL] [Abstract][Full Text] [Related]
62. Hyperoxia activates the ATR-Chk1 pathway and phosphorylates p53 at multiple sites.
Das KC; Dashnamoorthy R
Am J Physiol Lung Cell Mol Physiol; 2004 Jan; 286(1):L87-97. PubMed ID: 12959929
[TBL] [Abstract][Full Text] [Related]
63. Serine phosphorylation in the NH2 terminus of p53 facilitates transactivation.
Mayr GA; Reed M; Wang P; Wang Y; Schweds JF; Tegtmeyer P
Cancer Res; 1995 Jun; 55(11):2410-7. PubMed ID: 7757994
[TBL] [Abstract][Full Text] [Related]
64. Serine 15 phosphorylation of p53 directs its interaction with B56gamma and the tumor suppressor activity of B56gamma-specific protein phosphatase 2A.
Shouse GP; Cai X; Liu X
Mol Cell Biol; 2008 Jan; 28(1):448-56. PubMed ID: 17967874
[TBL] [Abstract][Full Text] [Related]
65. Interaction between transactivation domain of p53 and middle part of TBP-like protein (TLP) is involved in TLP-stimulated and p53-activated transcription from the p21 upstream promoter.
Maeda R; Suzuki H; Tanaka Y; Tamura TA
PLoS One; 2014; 9(3):e90190. PubMed ID: 24594805
[TBL] [Abstract][Full Text] [Related]
66. Cabin1 restrains p53 activity on chromatin.
Jang H; Choi SY; Cho EJ; Youn HD
Nat Struct Mol Biol; 2009 Sep; 16(9):910-5. PubMed ID: 19668210
[TBL] [Abstract][Full Text] [Related]
67. Phosphorylation of serine 392 in p53 is a common and integral event during p53 induction by diverse stimuli.
Cox ML; Meek DW
Cell Signal; 2010 Mar; 22(3):564-71. PubMed ID: 19932175
[TBL] [Abstract][Full Text] [Related]
68. Phosphorylation of p53: a novel pathway for p53 inactivation in human T-cell lymphotropic virus type 1-transformed cells.
Pise-Masison CA; Radonovich M; Sakaguchi K; Appella E; Brady JN
J Virol; 1998 Aug; 72(8):6348-55. PubMed ID: 9658074
[TBL] [Abstract][Full Text] [Related]
69. Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells.
Maddocks OD; Berkers CR; Mason SM; Zheng L; Blyth K; Gottlieb E; Vousden KH
Nature; 2013 Jan; 493(7433):542-6. PubMed ID: 23242140
[TBL] [Abstract][Full Text] [Related]
70. p53 Phosphorylation at serine 15 is required for transcriptional induction of the plasminogen activator inhibitor-1 (PAI-1) gene by the alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine.
Parra M; Jardí M; Koziczak M; Nagamine Y; Muñoz-Cánoves P
J Biol Chem; 2001 Sep; 276(39):36303-10. PubMed ID: 11470783
[TBL] [Abstract][Full Text] [Related]
71. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.
Shieh SY; Ikeda M; Taya Y; Prives C
Cell; 1997 Oct; 91(3):325-34. PubMed ID: 9363941
[TBL] [Abstract][Full Text] [Related]
72. Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma.
Wu CE; Esfandiari A; Ho YH; Wang N; Mahdi AK; Aptullahoglu E; Lovat P; Lunec J
Br J Cancer; 2018 Feb; 118(4):495-508. PubMed ID: 29235570
[TBL] [Abstract][Full Text] [Related]
73. Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215.
Liu Q; Kaneko S; Yang L; Feldman RI; Nicosia SV; Chen J; Cheng JQ
J Biol Chem; 2004 Dec; 279(50):52175-82. PubMed ID: 15469940
[TBL] [Abstract][Full Text] [Related]
74. Ser46 phosphorylation of p53 is not always sufficient to induce apoptosis: multiple mechanisms of regulation of p53-dependent apoptosis.
Kurihara A; Nagoshi H; Yabuki M; Okuyama R; Obinata M; Ikawa S
Genes Cells; 2007 Jul; 12(7):853-61. PubMed ID: 17584297
[TBL] [Abstract][Full Text] [Related]
75. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
76. Paradoxical suppression of cellular senescence by p53.
Demidenko ZN; Korotchkina LG; Gudkov AV; Blagosklonny MV
Proc Natl Acad Sci U S A; 2010 May; 107(21):9660-4. PubMed ID: 20457898
[TBL] [Abstract][Full Text] [Related]
77. Mutations in serines 15 and 20 of human p53 impair its apoptotic activity.
Unger T; Sionov RV; Moallem E; Yee CL; Howley PM; Oren M; Haupt Y
Oncogene; 1999 May; 18(21):3205-12. PubMed ID: 10359526
[TBL] [Abstract][Full Text] [Related]
78. Limited role of N-terminal phosphoserine residues in the activation of transcription by p53.
Jackson MW; Agarwal MK; Agarwal ML; Agarwal A; Stanhope-Baker P; Williams BR; Stark GR
Oncogene; 2004 May; 23(25):4477-87. PubMed ID: 15064747
[TBL] [Abstract][Full Text] [Related]
79. Protein kinase C delta regulates Ser46 phosphorylation of p53 tumor suppressor in the apoptotic response to DNA damage.
Yoshida K; Liu H; Miki Y
J Biol Chem; 2006 Mar; 281(9):5734-40. PubMed ID: 16377624
[TBL] [Abstract][Full Text] [Related]
80. p53 tumor suppressor protein stability and transcriptional activity are targeted by Kaposi's sarcoma-associated herpesvirus-encoded viral interferon regulatory factor 3.
Baresova P; Musilova J; Pitha PM; Lubyova B
Mol Cell Biol; 2014 Feb; 34(3):386-99. PubMed ID: 24248600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
